Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 5)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 5)

Results 81 - 100 of 827 in Lipitor, Atorvastatin (generic)

  1. Use of cholesterol-lowering meds on the riseRead the original story w/Photo

    Dec 24, 2014 | Fox News

    The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds. In 2012, the percentage of people ages 40 and over who said they had used a cholesterol-lowering medication in the past month was 28 percent, up from 20 percent in 2003, according to the report from the Centers for Disease Control and Prevention.


  2. Statins cause brain dysfunctionRead the original story w/Photo

    Dec 22, 2014 |

    Statins are the most profitable medications in the history of Big Pharma. They are promoted as the go-to medications to prevent/treat heart disease.


  3. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes New Study Linking...Read the original story

    Dec 19, 2014 | Personal Injury Law News

    The study's publication comes amid a growing number of Lipitor lawsuit filings on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of the cholesterol-lowering statin.


  4. AstraZeneca will outsource Crestor API following UK plant closureRead the original story w/Photo

    Dec 19, 2014 | Drug Researcher

    The closure of an API plant in the UK will lead to opportunities for third party manufacturers, AstraZeneca has said. The decision to shutter the Avlon plant, near Bristol, was originally taken in 2008 but this week the company told our sister publication the site would close its doors by early 2017.


  5. 3 Pharma Giants Growing Significantly Faster Than Pfizer, Inc.Read the original story w/Photo

    Dec 19, 2014 | The Motley Fool

    It's no secret why: Pfizer has a well-diversified portfolio of pharmaceuticals products that tend to perform well in robust as well as recessionary environments. However, there's one big problem with Pfizer : It's currently suffering from a monstrous patent cliff whereby some of its key drugs are losing their exclusivity and being exposed to generic competition, which costs just a fraction of what branded drugs usually run.


  6. Selecting a Database for Drug Literature Retrieval: A Comparison of...Read the original story

    Dec 18, 2014 | CiteULike

    Three widely used databases?MEDLINE, Scopus, and Web of Science?were compared for their relative ability to retrieve the largest number of articles within the drug literature, using three search terms: two for specific drugs and one for a major class of drugs . These drugs and the class of drugs were chosen for their longevity and continued high clinical and scientific interest, as indicated by the many articles concerning them published in scholarly and professional journals over the last two decades.


  7. AstraZeneca API plant set to shut by 2017 as Patent Cliff strikes againRead the original story w/Photo

    Dec 18, 2014 |

    An AstraZeneca API plant in Bristol, UK will close its doors within two years due to patent expirations of its cholesterol-lowering blockbuster Crestor. 2013 sales of AstraZeneca's cardiovascular drug Crestor decreased 8% on the previous year to $5.6bn due to erosion from patent expiration in certain markets.


  8. Did You Take These Drugs?Read the original story w/Photo

    Dec 17, 2014 | OpEdNews

    It's no secret that direct-to-consumer drug advertising made drugs like Viagra, Lipitor, Prozac or Nexium into rock stars. What is less apparent is how many new drugs betrayed serious risks after millions took them.


  9. Rise Of The Indian Drug Industry Demands Improved RegulationRead the original story w/Photo

    Dec 17, 2014 | The Daily Caller

    A major Indian biotechnology company just announced it is breaking into the exciting field of biologic medicines. Zydus-Cadila has successfully manufactured a rough copy of a popular autoimmune disease biologic called Humira.


  10. London Sewer Cleaners Fighting FatbergsRead the original story w/Photo

    Dec 16, 2014 |

    London Sewer Cleaners Fighting Fatbergs: Every day beneath the streets of London, sewer technicians are fighting a grim war against giant 'fatbergs' - or accumulated fat pockets in the sewers caused by people dumping grease such as turkey fat down their sinks - which clog the system and threaten to regurgitate putrid waste back into people's homes. All I know is, finding those fat deposits must have required one hell of a colonoscopy.


  11. Is This The Future Of Late-Stage Drug Development?Read the original story w/Photo

    Dec 15, 2014 |

    As DrugBaron, I have blogged extensively on healthcare generally, and the pharma industry in particular, over the last five years. I am a Partner at Index Ventures, based in London, with particular focus on company creation and early stage investment in the life sciences, building on my experience over twenty years as an academic at Cambridge University.


  12. 3 Traits of the Best Healthcare Stocks in 2014Read the original story w/Photo

    Dec 15, 2014 | The Motley Fool

    Just when it looked as though the stock market couldn't possibly finish the year higher, after its swoon in October, it proved the naysayers wrong. As of this writing, the S&P 500 has risen by 11% for the year, a tad bit higher than the stock markets' historic annual return.


  13. A costly anomaly on a brain MRIRead the original story w/Photo

    Dec 14, 2014 | Kevin, M.D.

    It started with a mild case of nausea and got progressively worse. I became dizzy and shaky, but tried to ignore it.


  14. Early statin use may give long-term heart benefitsRead the original story w/Photo

    Dec 14, 2014 |

    Taking a cholesterol-lowering drug for five years in middle age can lower heart and death risks for decades afterward, and the benefits seem to grow over time, a landmark study finds.


  15. Pure White Mulberry Leaf Extract Garners Favorable Feedback from UsersRead the original story w/Photo

    Dec 13, 2014 | LivePressWorld

    With an increasing number of people becoming reluctant to use weight loss supplements, it has become difficult for supplements to receive positive reviews by the general populace. Defying the odds, the White Mulberry Leaf Extract Pure by BioGanix has taken the market by storm and received positive reviews at X 13, December 2014: Developed to help millions around the world achieve their fitness goals, weight loss supplements have come under increasing scrutiny with time.


  16. Elderly should take cholesterol-lowering statins, says studyRead the original story w/Photo

    Dec 12, 2014 | The Star Online

    New guidelines recommend statins not only for people with cardiovascular disease, diabetes, or high levels of bad cholesterol, but also for adults who are at risk of such diseases. - Shutterstock Nearly everyone aged 66 to 75 should consider taking cholesterol-lowering drugs called statins to reduce their risk of heart attack and stroke, new guidelines says.


  17. Government imposes price caps on 52 drug formulationsRead the original story

    Dec 12, 2014 | The Telegraph

    New Delhi, Dec. 12: The Union government today imposed price caps on 52 new formulations of drugs, including several antibiotics, pain-killers, and vitamins, but most of these drugs are already under price control as other formulations. The National Pharmaceutical Pricing Authority today announced ceiling retail prices on the formulations, several of which include combinations of drugs to infections, diabetes, or high blood pressure but already under price control.


  18. Book Review: 'The Book Case,' A Police Thriller by Nelson DeMilleRead the original story w/Photo

    Dec 11, 2014 | Seattle Post-Intelligencer

    The Book Case is one of DeMille's stories where a charming prose blends suspense, a crime puzzle solution and a subtle sense of humor. Funny for some, his humour is not for everyone; rather it is for those who appreciate it, and understand it well.


  19. Recent Study Reveals Potential Association Between Lipitor, Other...Read the original story w/Photo

    Dec 11, 2014 | PRWeb

    The study found that use of Lipitor and other statins may be tied to a significant increased risk for development of the ocular disorder. Parker Waichman LLP , a national law firm that has long been dedicated to protecting the rights of consumers who have suffered injuries due to dangerous drugs comments on two recent studies reviewed potential associations between statins and possible increased risks for cataract development.


  20. Lipitor Lawsuit Parties Scheduled to Submit Joint Status Report, Bernstein Liebhard LLP ReportsRead the original story w/Photo

    Dec 11, 2014 | PRWeb

    More than 1,400 Lipitor lawsuits have been filed in federal court on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the statin medication. Our Firm continues to hear from Lipitor patients who allegedly developed new-onset Type 2 diabetes due to their use of this medication.